Back
ESC Premium Access

a tertiary centre experience comparing new temperature-controlled high-power short-duration ablation technology with standard radiofrequency and cryo-energy ablation

Session: Arrhythmias e-posters
Topic: Catheter Ablation of Arrhythmias
Speaker: Doctor A. Mavilakandy (Leicester, GB)
Event: ESC Congress 2021 - The Digital Experience

Congress Presentation

0

About the speaker

Doctor Akash Mavilakandy

University of Leicester, Leicester (United Kingdom of Great Britain & Northern Ireland)
0 follower

114 more presentations in this session

Low voltage in limb leads in arrhythmogenic cardiomyopathy.

Speaker: Associate Professor S. Peters (Norden, DE)

Access
Abstract
Slides
0
Thumbnail

Secondary prevention implantable cardioverter-defibrillator (ICD) therapy in octogenarians: effective and safe

Speaker: Doctor C. Hauck (Regensburg, DE)

Access
Abstract
Slides
0
Thumbnail

Features of changes in left ventricular mechanics in patients with epicardial obesity

Speaker: Doctor O. Gritsenko (Barnaul, RU)

Access
Abstract
Slides
0
Thumbnail

Heart rate turbulence as potential adjuvant index for optimal treatment guidance in severe pulmonary artery hypertension.

Speaker: Doctor E. Simeonidou (Athens, GR)

Access
Abstract
Slides
0
Thumbnail

Comparison of clockwise and counterclockwise right atrial flutter using high-resolution mapping

Speaker: Professor A. Da Costa (Saint-Etienne, FR)

Access
Abstract
Slides
0
Thumbnail

Access the full session

Arrhythmias e-posters

Speakers: Doctor A. Mavilakandy, Associate Professor S. Peters, Doctor C. Hauck, Doctor O. Gritsenko, Doctor E. Simeonidou...
Access
0
Thumbnail

About the event

Image

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Congress
logo Image

Related content

Open Access

New recommendations for comorbidities.

27 August 2021

ESC Premium Access

Infective endocarditis causing by HACEK gram-negative bacteria presented with fever of unknow origin: The important of early echocardiogram.

27 August 2021

ESC Premium Access

Acute safety and performance outcomes from the inspIRE trial using a novel pulsed field ablation system for the treatment of paroxysmal atrial fibrillation

27 August 2021

ESC 365 is supported by

logo Novo Nordisk